Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.

Cabral de Menezes Filho, H; Rodrigues, J M; Radonsky, V; Della Manna, T; Kuperman, H; Steinmetz, L; Dichtchekenian, V; Damiani, D; Setian, N

Cabral de Menezes Filho, H; Rodrigues, J M; Radonsky, V; Della Manna, T; Kuperman, H; Steinmetz, L; Dichtchekenian, V; Damiani, D; Setian, N.

Affiliation

Cabral de Menezes Filho H; Pediatric Endocrinology Unit, Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Horm Res ; 68 Suppl 5: 207-8, 2007.

Article in En | MEDLINE | ID: mdl-18174750

Subject(s)

Alkaline Phosphatase/blood; Bone Density Conservation Agents/administration & dosage; Diphosphonates/administration & dosage; Osteogenesis Imperfecta/blood; Osteogenesis Imperfecta/drug therapy; Bone Density Conservation Agents/therapeutic use; Bone Remodeling/drug effects; Child; Child, Preschool; Diphosphonates/therapeutic use; Down-Regulation; Female; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Osteogenesis Imperfecta/physiopathology; Pamidronate; Severity of Illness Index

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis Imperfecta / Diphosphonates / Alkaline Phosphatase / Bone Density Conservation Agents Limits: Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Journal: Horm Res Year: 2007 Document type: Article Affiliation country: Brazil Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google